Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies.
Saved in:
| Title: | Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies. |
|---|---|
| Authors: | Phillip M; Institute for Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Mathieu C; Clinical and Experimental Endocrinology, University of Leuven, Leuven, Belgium., Lind M; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; Department of Medicine, NU-Hospital Group, Uddevalla, Sweden., Araki E; Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan., di Bartolo P; Ravenna Internal Medicine Department, Ravenna Diabetes Clinic, Romagna Local Health Authority, Ravenna, Italy., Bergenstal R; International Diabetes Center, Health Partners Institute, Minneapolis, Minnesota, USA., Heller S; Department of Oncology and Metabolism, University of Sheffield School of Medicine, Sheffield, UK., Hansen L; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Scheerer MF; BioPharmaceuticals Medical, AstraZeneca, Wedel, Germany., Thoren F; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Arya N; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Xu J; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Iqbal N; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Dandona P; Department of Endocrinology, Kaleida Health, Buffalo, New York, USA. |
| Corporate Authors: | DEPICT-1 and DEPICT-2 Investigators |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2021 Feb; Vol. 23 (2), pp. 549-560. Date of Electronic Publication: 2020 Nov 24. |
| Publication Type: | Clinical Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1463-1326 |
|---|---|
| DOI: | 10.1111/dom.14248 |
